E-Book, Englisch, Band 43, 506 Seiten
Advances in the Treatment Planning and Delivery of Radiotherapy.
E-Book, Englisch, Band 43, 506 Seiten
Reihe: Frontiers of Radiation Therapy and Oncology
ISBN: 978-3-8055-9681-7
Verlag: S. Karger
Format: PDF
Kopierschutz: Adobe DRM (»Systemvoraussetzungen)
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Bildgebende Verfahren, Nuklearmedizin, Strahlentherapie Nuklearmedizin, PET, Radiotherapie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Bildgebende Verfahren, Nuklearmedizin, Strahlentherapie Radiologie, Bildgebende Verfahren
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Bildgebende Verfahren, Nuklearmedizin, Strahlentherapie Magnetresonanztomographie, Computertomographie (MRT, CT)
Weitere Infos & Material
1;Cover;1
2;Contents;6
3;Preface;10
4;Introduction;12
4.1;Advances in the Planning and Delivery of Radiotherapy: New Expectations, New Standards of Care;12
4.1.1;Abstract;12
4.1.2;The Expansion of Radiation Oncology Technologies;12
4.1.3;Target Volume Specification and Treatment: Issues of Accuracy;16
4.1.4;Intensity-Modulated Radiation Therapy/Image-Guided Radiation Therapy Planning and Delivery Technologies: Current Challenges;19
4.1.5;Proton and Heavy Ion Radiation Therapy;30
4.1.6;Radiation Dose and Second Cancers;32
4.1.7;Radiation Oncology Informatics;34
4.1.8;Conclusions;35
4.1.9;References;37
5;General Concepts and Methods;40
5.1;Advanced Technologies in the Radiotherapy Clinic: System Fundamentals;40
5.1.1;Abstract;40
5.1.2;A Typical Intensity-Modulated Radiotherapy Treatment Planning System;41
5.1.3;Target Localization and Image Guidance;43
5.1.4;Image Registration;52
5.1.5;Adaptive Radiotherapy;61
5.1.6;References;66
6;Economic Perspectives;71
6.1;Controversies in the Adoption of New Healthcare Technologies;71
6.1.1;Abstract;71
6.1.2;Health Technology Assessment;71
6.1.3;Payment Policy Development: Past and Present Realities, and Future Uncertainties;77
6.1.4;Cost-Effectiveness Methodologies, Implications in an Era of Value-Based Purchasing;83
6.1.5;Conclusions;88
6.1.6;References;89
7;IMRT: Advances in Treatment Design and Delivery;91
7.1;Clinical Implementation of Intensity-Modulated Arc Therapy;91
7.1.1;Abstract;91
7.1.2;Intensity-Modulated Arc Therapy: Basic Concepts;92
7.1.3;Why Rotational Intensity-Modulated Radiation Therapy?;93
7.1.4;Commercial Intensity-Modulated Arc Therapy Solutions;96
7.1.5;Clinical Implementation of Intensity-Modulated Arc Therapy;99
7.1.6;References;108
8;IGRT: Advances in Targeting Therapy;110
8.1;4D Imaging and 4D Radiation Therapy: A New Era of Therapy Design and Delivery;110
8.1.1;Abstract;110
8.1.2;Impact of Breathing Motion on Images;111
8.1.3;Impact of Breathing Motion during Treatments;117
8.1.4;Methods to Account for Breathing Motion;120
8.1.5;Future Directions;126
8.1.6;Acknowledgements;127
8.1.7;References;127
8.2;Locating and Targeting Moving Tumors with Radiation Beams;129
8.2.1;Abstract;129
8.2.2;How Do We Locate the Moving Target?;133
8.2.3;How Do We Hit a Moving Target?;137
8.2.4;How Do We Create Integrated Systems to Locate and Hit Moving Targets?;139
8.2.5;Conclusions;139
8.2.6;References;140
9;Integrating IMRT and IGRT into Treatment Delivery;143
9.1;Technologies of Image Guidance and the Development of Advanced Linear Accelerator Systems for Radiotherapy;143
9.1.1;Abstract;143
9.1.2;Technologies to Meet the Goals of Image-Guided Radiation Therapy;146
9.1.3;Image Guidance Systems and Procedures;148
9.1.4;Cone-Beam CT for Linac-Based Image-Guided Radiation Therapy;154
9.1.5;Image Guidance: Meeting Future Needs;165
9.1.6;Conclusions;169
9.1.7;References;169
9.2;HelicalTomotherapy: Image-Guided and Adaptive Radiotherapy;176
9.2.1;Abstract;176
9.2.2;System Overview;177
9.2.3;Clinical Applications of Helical Tomotherapy;178
9.2.4;Daily Megavoltage-Based CT Imaging;179
9.2.5;Dose Evaluation and Adaptive Radiotherapy;186
9.2.6;Conclusions;190
9.2.7;References;190
9.3;The CyberKnife in Clinical Use: Current Roles, Future Expectations;192
9.3.1;Abstract;192
9.3.2;The CyberKnife System;192
9.3.3;Advances in CyberKnife Treatment Planning and Dose Delivery;194
9.3.4;Current Clinical Applications of CyberKnife;199
9.3.5;The Future of CyberKnife;202
9.3.6;References;203
10;Image Guidance and the New Practice of Radiotherapy: What to Know and Use from a Decade of Investigation;207
10.1;Abstract;207
10.2;The Rationale for Image-Guided Radiation Therapy: Perspectives on the Current Practice of Radiotherapy;207
10.3;Challenges in Image-Guided Radiation Therapy;213
10.4;Clinical Applications of Image-Guided Radiation Therapy;217
10.5;Adaptive Radiotherapy;223
10.6;Conclusions;225
10.7;References;226
11;Head and Neck Cancers;228
11.1;Intensity-Modulated and Image-Guided Radiation Therapy for Head and Neck Cancers;228
11.1.1;Abstract;228
11.1.2;Intensity-Modulated Radiation Therapy/Image-Guided Radiation Therapy Planning for Head and Neck Cancers;229
11.1.3;Intensity-Modulated Radiation Therapy for Nasopharyngeal Carcinomas;245
11.1.4;Intensity-Modulated Radiation Therapy for Oropharyngeal Carcinomas;256
11.1.5;Conclusions;260
11.1.6;Guidelines for Clinical Practice;261
11.1.7;References;262
11.2;Delineating Neck Targets for Intensity-Modulated Radiation Therapy of Head and Neck Cancer;266
11.2.1;Abstract;266
11.2.2;Tumor and Target Volumes in the Neck;267
11.2.3;Target Doses and Techniques;275
11.2.4;Case Studies;278
11.2.5;Guidelines for Clinical Practice;278
11.2.6;References;280
12;Thoracic Cancers;282
12.1;Motion Management and Image Guidance for Thoracic Tumor Radiotherapy: Clinical Treatment Programs;282
12.1.1;Abstract;282
12.1.2;Practical Strategies for Managing Respiratory Motion;283
12.1.3;Case Example: Clinical Procedures for Respiratory Gating;298
12.1.4;References;302
13;Breast Cancer;303
13.1;Intensity-Modulated Radiotherapy for Breast Cancer: Advances in Whole and Partial Breast Treatment;303
13.1.1;Abstract;303
13.1.2;Intensity-Modulated Radiotherapy and the Goals of Breast Radiotherapy;303
13.1.3;Improving Dose Homogeneity;305
13.1.4;Avoidance of Organs at Risk;308
13.1.5;Clinical Treatment Planning;311
13.1.6;Partial Breast Radiotherapy;315
13.1.7;Intensity-Modulated Radiotherapy and Partial Breast Irradiation;319
13.1.8;Guidelines for Clinical Practice;322
13.1.9;References;323
14;Abdominal Cancers;326
14.1;Image-Guided Radiotherapy Strategies in Upper Gastrointestinal Malignancies;326
14.1.1;Abstract;326
14.1.2;Immobilization and Motion Management in Upper Abdominal Malignancies;327
14.1.3;Image-Guided Radiotherapy for Pancreatic Cancer;328
14.1.4;Image-Guided Radiotherapy for Liver Cancer;336
14.1.5;Conclusions;338
14.1.6;Guidelines for Clinical Practice;339
14.1.7;Acknowledgements;340
14.1.8;References;340
15;Lymphomas;342
15.1;Radiotherapy Planning for the Lymphomas: Expanding Roles for Biologic Imaging;342
15.1.1;Abstract;342
15.1.2;Initial Staging;343
15.1.3;Response Evaluation;345
15.1.4;Radiation Therapy Planning;348
15.1.5;Clinical Trials Utilizing PET;352
15.1.6;Guidelines for Clinical Practice;353
15.1.7;References;354
16;Prostate Cancer;355
16.1;Image-Guided, Adaptive Radiotherapy of Prostate Cancer: Toward New Standards of Radiotherapy Practice;355
16.1.1;Abstract;355
16.1.2;Prostate Radiotherapy: A Model for Adaptive Image-Guided Radiotherapy;356
16.1.3;Dosimetric Impact of Motion in Prostate Radiotherapy;357
16.1.4;Solutions to Motion and Deformation in Prostate Image-Guided Radiotherapy;370
16.1.5;Guidelines for Clinical Practice;377
16.1.6;References;378
17;SBRT Advances;381
17.1;The Expanding Roles of Stereotactic Body Radiation Therapy and Oligofractionation: Toward a New Practice of Radiotherapy;381
17.1.1;Abstract;381
17.1.2;The Radiobiology of Stereotactic Body Radiation Therapy;382
17.1.3;Stereotactic Body Radiation Therapy Applications;385
17.1.4;Future Directions for Stereotactic Body Radiation Therapy;389
17.1.5;Conclusions;391
17.1.6;References;391
17.2;Stereotactic Body Radiation Therapy: Normal Tissue and Tumor Control Effects with Large Dose per Fraction;393
17.2.1;Abstract;393
17.2.2;Traditional Radiobiology;394
17.2.3;Modeling the Survival Curve;396
17.2.4;Biologically Equivalent Dose;397
17.2.5;Organ/Tissue Function and Microscopic Architecture;398
17.2.6;Serially Functioning Tissue Macroscopic Architecture;401
17.2.7;Stereotactic Body Radiation Therapy and Ablation;402
17.2.8;Normal Tissue Consequences of Ablative Dose Delivery;403
17.2.9;Tumor Control Dose;404
17.2.10;Conclusions;404
17.2.11;References;405
18;Thoracic Cancers;406
18.1;Stereotactic Body Radiation Therapy for Thoracic Cancers: Recommendations for Patient Selection, Setup and Therapy;406
18.1.1;Abstract;406
18.1.2;Prospective Testing of Stereotactic Body Radiation Therapy;407
18.1.3;A Guide to Stereotactic Body Radiation Therapy: Procedures and Practice;411
18.1.4;Guidelines for Clinical Practice;421
18.1.5;References;421
19;Gastrointestinal Cancers;423
19.1;Stereotactic Body Radiation Therapy for Gastrointestinal Malignancies;423
19.1.1;Abstract;423
19.1.2;Stereotactic Body Radiotherapy for Locally Advanced Pancreatic Cancers;424
19.1.3;Stereotactic Body Radiotherapy for Hepatic Malignancies;432
19.1.4;Guidelines for Clinical Practice;436
19.1.5;References;437
20;Genitourinary Cancers;439
20.1;Stereotactic Body Radiotherapy for Prostate Cancer: Current Results of a Phase II Trial;439
20.1.1;Abstract;439
20.1.2;Phase II Trial for Hypofractionated Radiotherapy of Prostate Cancer;439
20.1.3;Trial Results;444
20.1.4;Guidelines for Clinical Care;448
20.1.5;References;448
21;Techniques and Technologies;449
22;Proton Therapy: Clinical Gains through Current and Future Treatment Programs;449
22.1;Abstract;449
22.2;The State of the Art in Proton Therapy;451
22.3;Current and Future Developments in Clinical Proton Technology;460
22.4;Conclusions: Future Proton Technologies;472
22.5;References;473
23;Medical Applications and Advances;474
23.1;Proton Therapy in the Clinic;474
23.2;Abstract;474
23.3;Rationale for Protons;475
23.4;Protons: Clinical Advantages and Special Concerns;475
23.5;Proton Radiotherapy Treatment Planning;479
23.6;Issues in the Utilization of Proton Radiotherapy;482
23.7;Protons: Clinical Experience;484
23.8;Protons: How User Friendly?;489
23.9;Protons: Current Challenges;491
23.10;Guidelines for Clinical Practice;493
23.11;References;493
24;Author Index;495
25;Subject Index;496